Zurich Cantonal Bank’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-878
Closed -$50.8K 2860
2022
Q4
$50.8K Buy
878
+466
+113% +$28.8K ﹤0.01% 2597
2022
Q3
$39K Hold
412
﹤0.01% 2664
2022
Q2
$92K Hold
412
﹤0.01% 2301
2022
Q1
$226K Hold
412
﹤0.01% 1811
2021
Q4
$272K Buy
412
+73
+22% +$55.8K ﹤0.01% 1872
2021
Q3
$285K Hold
339
﹤0.01% 1675
2021
Q2
$431K Buy
339
+85
+33% +$95.9K ﹤0.01% 1310
2021
Q1
$279K Sell
254
-56
-18% -$73.9K ﹤0.01% 1586
2020
Q4
$442K Buy
310
+34
+12% +$36.3K ﹤0.01% 1354
2020
Q3
$195K Hold
276
﹤0.01% 1604
2020
Q2
$193K Buy
276
+136
+97% +$78.5K ﹤0.01% 1547
2020
Q1
$49K Hold
140
﹤0.01% 1946
2019
Q4
$88K Buy
+140
New +$68.5K ﹤0.01% 1794

Other funds holding CDLX

Zurich Cantonal Bank's CDLX Position: Q1 2023 in Review

Zurich Cantonal Bank sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 878 shares — an estimated $50.8K sold.

Zurich Cantonal Bank first reported a position in CDLX in Q4 2019 and held it in 13 quarters. The position peaked at $442K in Q4 2020. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Zurich Cantonal Bank reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 878 Cardlytics shares in Q1 2023, an estimated $50.8K.
  • Zurich Cantonal Bank first reported a position in Cardlytics in Q4 2019 and held it in 13 quarters.
  • Zurich Cantonal Bank's Cardlytics position peaked at $442K in Q4 2020.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.